Abiopharma

Savara Announces European Patent Office (EPO) Intends to Grant a Patent for the Liquid Formulation of MOLBREEVI*

TransCode Therapeutics and Quantum Leap Healthcare Collaborative Launch a Phase 2a dose-expansion trial with TTX-MC138, following positive readouts from TransCodes Phase 1 trial

DaVita Names New Leaders to Accelerate Care Transformation

Geron - Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation

A New Press Release from Elicio Therapeutics

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Baxter International Inc. with Losses of $100,000 to Contact the Firm

MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX

60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026

MAIA Leadership Continues Insider Buying in 2025 and Trial Data Signals Breakout Potential

NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx